Westfield Capital Management Co. LP Trims Stake in Cencora, Inc. $COR

Westfield Capital Management Co. LP lowered its stake in shares of Cencora, Inc. (NYSE:COR) by 2.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 319,215 shares of the company’s stock after selling 6,445 shares during the period. Westfield Capital Management Co. LP’s holdings in Cencora were worth $107,815,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of COR. Vestcor Inc grew its holdings in Cencora by 0.5% in the third quarter. Vestcor Inc now owns 5,196 shares of the company’s stock worth $1,624,000 after purchasing an additional 28 shares during the period. JFS Wealth Advisors LLC grew its holdings in Cencora by 30.2% in the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock worth $42,000 after purchasing an additional 29 shares during the period. Apollon Wealth Management LLC grew its holdings in Cencora by 0.5% in the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock worth $2,205,000 after purchasing an additional 30 shares during the period. Accent Capital Management LLC grew its holdings in Cencora by 36.1% in the fourth quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock worth $38,000 after purchasing an additional 30 shares during the period. Finally, CYBER HORNET ETFs LLC grew its holdings in Cencora by 6.8% in the fourth quarter. CYBER HORNET ETFs LLC now owns 485 shares of the company’s stock worth $164,000 after purchasing an additional 31 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. UBS Group upped their price objective on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. upped their price objective on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Robert W. Baird cut their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a report on Thursday, May 7th. Finally, Wells Fargo & Company cut their price objective on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Cencora has an average rating of “Moderate Buy” and an average price target of $380.25.

Cencora Trading Up 2.5%

Shares of NYSE COR opened at $270.12 on Friday. The firm’s 50 day moving average price is $293.70 and its 200-day moving average price is $330.94. The company has a market cap of $52.55 billion, a PE ratio of 20.71, a P/E/G ratio of 1.42 and a beta of 0.59. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities research analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.

Cencora declared that its Board of Directors has authorized a share buyback plan on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its shares are undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.